MedTrace Logo

Lower Protein Intake and Long-term Risk of Obesity and Cardiovascular Disease

NCT03456934 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 249

Last updated 2023-03-17

No results posted yet for this study

Summary

The primary objective of this study is to investigate if consumption of lower protein formula can slow the rate of weight gain of formula-fed infants between 3 and 12 months of age. Secondary objectives include investigation into whether infant nutrition and growth have an impact on later risk of obesity and cardiovascular disease.

Conditions

  • Infant Formula
  • Growth

Interventions

OTHER

Modified infant formula

Test formula with lower protein content than standard formula

OTHER

Standard infant formula

Standard infant formula

Sponsors & Collaborators

  • University College, London

    collaborator OTHER

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Atul Singhal, MD · Childhood Nutrition Research Centre, University College London, Institute of Child Health

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
13 Weeks
Max Age
15 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-07
Primary Completion
2021-09-30
Completion
2022-10-13

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03456934 on ClinicalTrials.gov